Journal of Nanomedicine & Biotherapeutic Discovery : Citations & Metrics Report
Articles published in Journal of Nanomedicine & Biotherapeutic Discovery have been cited by esteemed scholars and scientists all around the world. Journal of Nanomedicine & Biotherapeutic Discovery has got h-index 18, which means every article in Journal of Nanomedicine & Biotherapeutic Discovery has got 18 average citations.
Following are the list of articles that have cited the articles published in Journal of Nanomedicine & Biotherapeutic Discovery.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
60 | 58 | 30 | 53 | 55 | 7 | 8 | 11 | 12 | 12 | 23 | 10 |
Research, Review articles and Editorials |
1 | 1 | 3 | 0 | 7 | 2 | 7 | 9 | 12 | 11 | 23 | 10 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
39 | 57 | 27 | 53 | 48 | 5 | 1 | 2 | 0 | 1 | 0 | 0 |
Conference proceedings |
0 | 0 | 9 | 4 | 0 | 0 | 38 | 0 | 0 | 0 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
96 | 142 | 167 | 194 | 193 | 164 | 152 | 94 | 102 | 58 | 20 | 17 |
| Journal total citations count | 1504 |
| Journal impact factor | 4.02 |
| Journal 5 years impact factor | 5.31 |
| Journal cite score | 5.37 |
| Journal h-index | 18 |
| Journal h-index since 2019 | 15 |
Important citations (752)
srilatha b (2011) nanotechnology in agriculture. j. nanomed nanotechnol 2: 5. |
|
Use of liposomal nanoformulations in antileishmania therapy: challenges and perspectives |
|
dell'orco d, lundqvist m, cedervall t, linse s (2012) delivery success rate of engineered nanoparticles in the presence of the protein corona: a systems-level screening. nanomedicine 8: 1271-1281. |
|
sahneh fd, scoglio cm, monteiro-riviere na, riviere je (2015) predicting the impact of biocorona formation kinetics on interspecies extrapolations of nanoparticle biodistribution modeling. nanomed 10: 25-33. |
|
lazarovits j, chen yy, sykes ea, chan wc(2015) nanoparticle–blood interactions: the implications on solid tumour targeting. chem commun 51: 2756-2767. |
|
Electrospun thermo-responsive nanofibers of poly (hydroxyethylacrylate-co-coumaryl acrylate-co-ethylmethacrylate) |
|
Production of electrospun chitosan for biomedical applications |
|
Mohanan dp, augustine r, kalarikkal n, radhakrishnan ek, thomas s et al.(2016) electrospun matrices for biomedical applications: recent advances. innanomedicine and tissue engineering 365-390. |
|
electrospun nanofibers |
|
The facile synthesis of chitosan-based silver nano-biocomposites via a solution plasma process and their potential antimicrobial efficacy |
|
Magnesium incorporated polycaprolactone-based composite nanofibers |
|
fibers functionalized with cyclodextrins and their inclusion complexes. |
|
Fabrication and characterization of electrospun pcl-mgo-keratin-based composite nanofibers for biomedical applications |
|
Enhanced mechanical properties of poly (?-caprolactone) nanofibers produced by the addition of non-stoichiometric inclusion complexes of poly (?-caprolactone) and … |
|
Electrospinning, mechanical properties, and cell behavior study of chitosan/pva nanofibers |
|
Effects of chitosan alkali pretreatment on the preparation of electrospun pcl/chitosan blend nanofibrous scaffolds for tissue engineering application |
|
Poly(?-caprolactone)/keratin-based composite nanofibers for biomedical applications |
|
Nanoclay-reinforced electrospun chitosan/pva nanocomposite nanofibers for biomedical applications |
|
Drug-loaded electrospun materials in wound-dressing applications and in local cancer treatment |
|
Electrospun chitosan nanofibers with controlled levels of silver nanoparticles. preparation, characterization and antibacterial activity |
|